L.B.J. van Iersel

Isolated hepatic melphalan perfusion of colorectal liver metastases: outcome and prognostic factors in 154 patients

L.B.J. van Iersel, Hans Gelderblom, Alexander L. Vahrmeijer et al. · Annals of Oncology · 2008 · 46 citations · Full text

Hepatic Melphalan Perfusion, Prognostic Factors, Surgical Oncology +13

Isolated Hepatic Perfusion with 200 mg Melphalan for Advanced Noncolorectal Liver Metastases

L.B.J. van Iersel, Ellen J. Hoekman, Hans Gelderblom et al. · Annals of Surgical Oncology · 2008 · 45 citations · Full text

Hepatic artery infusion of high-dose melphalan at reduced flow during isolated hepatic perfusion for the treatment of colorectal metastases confined to the liver: A clinical and pharmacologic evaluation

L.B.J. van Iersel, M. Verlaan, Alexander L. Vahrmeijer et al. · European Journal of Surgical Oncology · 2007 · 28 citations

Reduced Flow, Hepatology, Health Sciences +11

Management of isolated nonresectable liver metastases in colorectal cancer patients: a case–control study of isolated hepatic perfusion with melphalan versus systemic chemotherapy

L.B.J. van Iersel, Miriam Koopman, Cornelis J.�H. van de Velde et al. · Annals of Oncology · 2010 · 26 citations · Full text

Surgical Oncology, Hepatology, Health Sciences +14

Isolated hepatic perfusion with oxaliplatin combined with 100 mg melphalan in patients with metastases confined to the liver: A phase I study

L.B.J. van Iersel, Emily Leede, Alexander L. Vahrmeijer et al. · European Journal of Surgical Oncology · 2014 · 17 citations

Hepatology, Medicine, Liver Physiology +11